مورد إلكتروني
Smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom prostate
| العنوان: | Smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom prostate |
|---|---|
| عناروين إضافية: | Clinical Recommendation for Diagnostics, Treatment and Monitoring of Patients with Prostate Cancer |
| المصدر: | Liječnički vjesnik; ISSN 0024-3477 (Print); ISSN 1849-2177 (Online); Volume 141; Issue 11-12 |
| بيانات النشر: | Croatian medical association 2019 |
| تفاصيل مُضافة: | Mladen Solarić Ana Fröbe Dražen Huić Dag Zahirović Željko Kaštelan Stela Bulimbašić Igor Tomašković Tomislav Kuliš Marija Gamulin Blanka Jakšić Vesna Bišof Ante Punda Tomislav Omrčen Tihana Boraska Jelavić Katarina Vilović Ana Marija Alduk Kristijan Krpina Tomislav Sorić Zvonimir Curić |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Adenokarcinom prostate najčešća je zloćudna neoplazma u muškaraca u Republici Hrvatskoj. Klinički je često asimptomatski, a najčešće se otkriva na osnovi povišenih vrijednosti PSA u serumu. Odluka o liječenju donosi se na temelju TNM-klasifikacije, gradusne skupine i vrijednosti PSA. Klinički lokalizirana bolest vrlo se uspješno liječi radikalnom prostatektomijom ili radikalnom radioterapijom s hormonskom terapijom ili bez nje. Klinički lokalno uznapredovala bolest najčešće se liječi združenom primjenom radikalne radioterapije i hormonske terapije. Metastatska bolest godinama se može kontrolirati androgenom deprivacijom, a nakon razvoja kastracijski rezistentne bolesti opravdani su kemoterapija ili dodatni oblici hormonske terapije. U radu su prikazane kliničke upute radi ujednačenja postupaka i kriterija postavljanja dijagnoze, liječenja i praćenja bolesnika s rakom prostate u Republici Hrvatskoj. Prostate adenocarcinoma is the most common solid neoplasm in male population in Croatia. It is often asymptomatic. The finding of PSA rise is the most common reason for diagnostic workout. Treatment plan is based on TNM classification, grade group and PSA. Clinically localized disease is successfully treated by radical prostatectomy or radiotherapy with or without hormonal therapy. Locally advanced disease is treated with radiotherapy and hormonal therapy. Metastatic disease can be controlled for many years by androgen deprivation. For castration resistant metastatic disease appropriate treatment is chemotherapy or secondary hormonal therapy. The following paper presents the clinical guidelines to standardize procedures for the diagnosis, treatment and follow-up of patients with prostate cancer in the Republic of Croatia. |
| مصطلحات الفهرس: | TUMORI PROSTATE – dijagnoza, liječenje, patologija; ADENOKARCINOM – dijagnoza, liječenje, patologija; ANTIGEN SPECIFIČAN ZA PROSTATU – u krvi; TUMORSKI STADIJ; PROSTATEKTOMIJA – metode; RADIOTERAPIJA; HORMONSKI PROTUTUMORSKI LIJEKOVI – terapijska uporaba; ANTIANDROGENI – terapijska uporaba; PROTUTUMORSKI KEMOTERAPIJSKI PROTOKOLI – terapijska uporaba; MULTIMODALNO LIJEČENJE; SMJERNICE; HRVATSKA, PROSTATIC NEOPLASMS – diagnosis, pathology, thetapy; ADENOCARCINOMA – diagnosis, pathology, thetapy; PROSTATE-SPECIFIC ANTIGEN – blood; NEOPLASM STAGING; PROSTATECTOMY – methods; RADIOTHERAPY; ANTINEOPLASTIC AGENTS, HORMONAL – therapeutic use; ANDROGEN ANTAGONISTS – therapeutic use; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS – therapeutic use; COMBINED MODALITY THERAPY; PRACTICE GUIDELINES AS TOPIC; CROATIA, text, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion |
| URL: | info:eu-repo/semantics/altIdentifier/doi/10.26800/LV-141-11-12-41 |
| الإتاحة: | Open access content. Open access content info:eu-repo/semantics/openAccess The Medical Journal is an open access journal. The content of the magazine is available in its entirety free of charge. The contents of the Medical Journal may be reproduced with the quotation "taken from the Medical Journal". Users may not use the materials for commercial purposes, may not modify, redesign or rework the material. |
| ملاحظة: | application/pdf Croatian |
| أرقام أخرى: | HRCAK oai:hrcak.srce.hr:232846 1137599061 |
| المصدر المساهم: | HRCAK PORTAL ZNANSTVENIH CASOPISA REPUB From OAIster®, provided by the OCLC Cooperative. |
| رقم الأكسشن: | edsoai.on1137599061 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |